Human insulin analogue [LYS(B28), PRO(B29)]: the ideal pump insulin?

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Diabetic Medicine

• Publication date

  1998-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/(SICI)1096-9136(199803)15:3<247::AID-DIA547>3.0.CO;2-TPMID 9545126
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes.

  2009cited by this paper
• Reduction of Postprandial Hyperglycemia and Frequency of Hypoglycemia in IDDM Patients on Insulin-Analog Treatment

  1997cited by this paper
• Insulin lispro.

  1997cited by this paper
• Strategies Toward Improved Control During Insulin Lispro Therapy in IDDM: Importance of basal insulin

  1997cited by this paper
• Bioavailability and Bioeffectiveness of Subcutaneous Human Insulin and Two of its Analogs—LysB28ProB29-Human Insulin and AspB10LysB28ProB29-Human Insulin—Assessed in a Conscious Pig Model

  1997cited by this paper
• Health-Related Quality-of-Life Results From Multinational Clinical Trials of Insulin Lispro: Assessing benefits of a new diabetes therapy

  1997cited by this paper
• Insulin Lispro in CSII: Results of a Double-Blind Crossover Study

  1997influential reference
• Pre‐meal Insulin Analogue Insulin Lispro vs Humulin® R Insulin Treatment in Young Subjects with Type 1 Diabetes

  1996cited by this paper
• Immunologic Effects of Insulin Lispro [Lys (B28), Pro (B29) Human Insulin] in IDDM and NIDDM Patients Previously Treated With Insulin

  1996cited by this paper
• Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen

  1995cited by this paper
• Role of C-terminal B-chain residues in insulin assembly: the structure of hexameric LysB28ProB29-human insulin.

  1995cited by this paper
• Effect of the Insulin Analogue [LYS(B28),PRO(B29)] on Blood Glucose Control

  1994cited by this paper
• Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM

  1994cited by this paper
• Improving insulin therapy: achievements and challenges.

  1994cited by this paper
• [Lys(B28), Pro(B29)]-Human Insulin: A Rapidly Absorbed Analogue of Human Insulin

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• New Directions in Drug Development: Mixtures, Analogues, and Modeling

  1993cited by this paper

• Guía de práctica clínica sobre Diabetes Mellitus Tipo 1

  2026cites this paper
• Controlador Bi-hormonal por Modos Deslizantes Aplicado à Regulação de Glicemia em Pacientes Diabéticos Tipo 1

  2018cites this paper
• Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis

  2018cites this paper
• An overview of insulin pump therapy: appropriate use of an expensive resource

  2012cites this paper
• Rapid-Acting Insulin Analogues for the Treatment of Diabetes Mellitus: Meta-analyses of Clinical Outcomes.

  2010cites this paper
• Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.

  2010cites this paper
• Approaches to the management of postprandial hyperglycaemia

  2009cites this paper
• Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis

  2009cites this paper
• Evidence-based insulin treatment in type 1 diabetes mellitus.

  2009cites this paper
• An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK

  2009cites this paper
• Experimentelle Untersuchungen und klinische Evidenz der Insulinpumpentherapie (CSII)

  2009cites this paper
• Iconography : Comment utiliser l'analogue de l'insuline Lys-Pro en perfusion sous-cutanée continue par pompe portable ?

  2008cites this paper
• [Insulin pump therapy in patients with type 1 diabetes].

  2008cites this paper
• Canadian Agency for Drugs and Technologies in Health Short-acting Insulin Analogues for Diabetes Mellitus

  2007cites this paper
• A false paradise - mixed blessings in the protein universe: the amyloid as a new challenge in drug development.

  2007cites this paper
• Long-acting insulin analogues for diabetes mellitus: meta-analysis of clinical outcomes and assessment of cost-effectiveness

  2007cites this paper
• Continuous Blood Glucose Monitoring and Insulin Pumps

  2006cites this paper
• Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

  2006cites this paper
• Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

  2006cites this paper
• Type 1 Diabetes in Children, Adolescents, and Young Adults: How to Become an Expert on Your Own Diabetes

  2006cites this paper
• Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus.

  2005cites this paper
• Patient management of long-term continuous subcutaneous insulin infusion.

  2005cites this paper
• Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy

  2004cites this paper
• Continuous subcutaneous insulin infusion with short‐acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost‐effectiveness

  2004cites this paper
• CONTINUOUS SUBCUTANEOUS INSULIN INFUSION ( CSII )

  2004cites this paper
• Insulin Pump Therapy in Children and Adolescents with Type 1 Diabetes - Personal Observations Własne obserwacje leczenia cukrzycy typu 1 u dzieci i młodzieży za pomocą osobistej pompy insulinowej

  2004cites this paper
• Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta‐analysis

  2003cites this paper
• Open- and Closed-Loop Insulin Delivery Systems and Glucose Sensors

  2003cites this paper
• Insulin pumps

  2003cites this paper
• Insulin, glucagon, and hypoglycemic drugs

  2003cites this paper
• Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials

  2002cites this paper
• Assessment of therapy with continuous subcutaneous insulin infusion in an academic diabetes clinic.

  2002cites this paper
• Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.

  2002cites this paper
• Lispro insulin treatment in comparison with regular human insulin in type 2 diabetic patients living in nursing homes.

  2002cites this paper
• Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy.

  2001cites this paper
• Revisão da hiperglicemia pós-prandial e a hipoglicemia no controle do diabetes mellitus: o papel da insulina lispro e suas pré-misturas nos picos e vales

  2001cites this paper
• Recent advances in the pharmacologic management of diabetes mellitus.

  2000cites this paper
• Impact of insulin lispro on HbA1c values in insulin pump users

  2000cites this paper
• A Rational Approach to Drug Therapy of Type 2 Diabetes Mellitus

  2000cites this paper
• Improved blood glucose variability, HbA1c insuman Infusat and less insulin requirement in IDDM patients using insulin lispro in CSII. The Swedish Multicenter Lispro Insulin Study.

  2000cites this paper
• Insulin Lispro (Humalog)

  1999cites this paper
• Traitement du diabète de type 1 (diabète insulinodépendant)

  1999cites this paper
• Insulin lispro: the ideal pump insulin for patients with severe hypoglycemic unawareness?

  1999cites this paper
• Hypoglycemia and insulin analogues: is there a reduction in the incidence?

  1999cites this paper